Fate Therapeutics News

Fate Therapeutics Analyst Ratings

BenzingaMay 16 07:38 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Fate Therapeutics (FATE), Acumen Pharmaceuticals (ABOS) and DENTSPLY SIRONA (XRAY)

TipRanksMay 16 06:17 ET

Fate Therapeutics: Advancements and Differentiation in Autoimmune and Cancer Therapies Support Buy Rating

TipRanksMay 16 06:11 ET

Stifel Nicolaus Sticks to Their Hold Rating for Fate Therapeutics (FATE)

TipRanksMay 15 22:05 ET

Hold Rating on Fate Therapeutics Amid Pending Clinical Data and Strategic Pipeline Focus

TipRanksMay 14 04:46 ET

Fate Therapeutics Analyst Ratings

BenzingaMay 10 09:17 ET

Analysts Offer Insights on Healthcare Companies: Chemomab Therapeutics (CMMB), Fate Therapeutics (FATE) and Disc Medicine (IRON)

TipRanksMay 10 08:30 ET

Wedbush Adjusts Fate Therapeutics' Price Target to $5 From $7, Keeps Neutral Rating

MT NewswiresMay 10 08:22 ET

Fate Therapeutics: Strategic Shifts Prompt Hold Rating Amidst Awaited Clinical Results

TipRanksMay 10 06:29 ET

Barclays Sticks to Their Buy Rating for Fate Therapeutics (FATE)

TipRanksMay 10 05:46 ET

Fate Therapeutics Analyst Ratings

BenzingaMay 6 08:22 ET

Wedbush Reiterates Neutral on Fate Therapeutics, Maintains $7 Price Target

BenzingaMay 6 08:23 ET

Fate Therapeutics (FATE) Gets a Hold From Wedbush

TipRanksMay 6 07:55 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Fate Therapeutics (FATE), Danaher (DHR) and Roche Holding AG (OtherRHHVF)

TipRanksApr 24 04:50 ET

Fate Therapeutics Analyst Ratings

BenzingaApr 23 13:11 ET

Analysts Offer Insights on Healthcare Companies: Fate Therapeutics (FATE), Disc Medicine (IRON) and Avita Medical (RCEL)

TipRanksApr 11 06:20 ET

Fate Therapeutics Analyst Ratings

BenzingaApr 11 06:08 ET

Fate Therapeutics Analyst Ratings

BenzingaMar 28 14:12 ET

Cautious Outlook on Fate Therapeutics: Sell Rating Maintained Amid Competitive and Validation Concerns

TipRanksMar 28 04:58 ET

Analysts Offer Insights on Healthcare Companies: Fate Therapeutics (FATE) and AbbVie (ABBV)

TipRanksMar 25 21:10 ET